Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.

AusPAR: Ulipristal acetate

Australian Public Assessment Report

AusPAR

AusPAR Ulipristal acetate [PDF, 613.95 KB]

AusPAR Ulipristal acetate [Word, 603.11 KB]

Attachment: Product Information: Ulipristal acetate [PDF, 199.75 KB]

Attachment: Product Information: Ulipristal acetate [Word, 112.27 KB]

Attachment: Extract from Clinical Evaluation Report: Ulipristal acetate [PDF, 1.1 MB]

Attachment: Extract from Clinical Evaluation Report: Ulipristal acetate [Word, 2.02 MB]

Device/Product Name

Esmya

Active ingredients

Ulipristal acetate

AusPAR Date

19 October 2016

Published

2 November 2016

Submission Number

PM-2015-00776-1-5

Submission Type

Extension of indications

Decision

Approved